Literature DB >> 3581105

Hickman catheter clots: a common occurrence despite daily heparin flushing.

A J Anderson, S H Krasnow, M W Boyer, M L Raucheisen, C E Grant, O R Gasper, J K Hoffmann, M H Cohen.   

Abstract

Central vein thrombosis is the major Hickman catheter complication in our patient population. After noting clots attached to the disposable infusion plug of these catheters, we prospectively determined whether the presence of clots indicated a high-risk group for thrombosis. Forty-three patients (41 with solid tumor, two with acute leukemia) were studied. Catheters were flushed daily with heparin (10 units/ml), and urokinase (5000-10,000 units) was injected when blood could not be drawn. Clots within the catheter lumen were detected visually after expressing, onto a 4 X 4-inch gauze pad, the first 5-10 ml of admixed blood and flush solution or iv infusion fluid drawn from the catheter prior to blood drawing. Clots were detected in 153 of 508 specimens (30%). Forty of 43 patients had clots, varying in length from fragments to 5 cm, in at least one specimen. Inpatients and outpatients had a similar percentage of clotted specimens. Eight patients developed clinical (six) or autopsy-proven (two) thrombosis. There was no difference between patients with and without thrombosis in percent of discards positive for clots. This study indicates that clots are frequently present in the lumina of Hickman catheters. It is likely that these clots embolize to the lungs when catheters are flushed. Consequences of embolization are unknown.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3581105

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  6 in total

1.  A central venous catheter for long-term studies on drug effects and pharmacokinetics in Munich minipigs.

Authors:  W Schmidt; A Dehn; J F Hutter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Apr-Jun       Impact factor: 2.441

2.  Necessity of heparin for maintaining peripheral venous catheters: A systematic review and meta-analysis.

Authors:  Tao You; Jianliang Jiang; Jianchang Chen; Weiting Xu; Li Xiang; Yang Jiao
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

3.  The use of an implantable central venous (Hickman) catheter for long-term venous access in dogs undergoing bone marrow transplantation.

Authors:  A C Abrams-Ogg; S A Kruth; R F Carter; V E Valli; S Kamel-Reid; I D Dubé
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

Review 4.  Anticoagulation for people with cancer and central venous catheters.

Authors:  Lara A Kahale; Ibrahim G Tsolakian; Maram B Hakoum; Charbel F Matar; Maddalena Barba; Victor Ed Yosuico; Irene Terrenato; Francesca Sperati; Holger Schünemann; Elie A Akl
Journal:  Cochrane Database Syst Rev       Date:  2018-06-01

5.  Tunnelled central venous catheter-related problems in the early phase of haematopoietic stem cell transplantation and effects on transplant outcome.

Authors:  Mahmut Yeral; Can Boğa; Levent Oğuzkurt; Hikmet Eda Alışkan; Hakan Özdoğu; Yusuf Ziya Demiroğlu
Journal:  Turk J Haematol       Date:  2015-03-05       Impact factor: 1.831

6.  Central venous line and acute neurological deficit: a case series.

Authors:  Seyed Hossein Ahmadi; Mahmood Shirzad; Sam Zeraatian; Abbas Salehiomran; Seyed Hesameddin Abbasi; Atefeh Ghiasi
Journal:  J Tehran Heart Cent       Date:  2014-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.